
Will there be at least 10000 measles cases in the U.S. in 2026?
Measles cases in U.S. in 2026?
AI analysis
The market resolves Yes if confirmed measles cases in the U.S. during calendar year 2026 reach or exceed 10,000. That is an extremely high bar: the 2019 outbreak peak saw about 1,274 cases, and 2024 recorded roughly 280. The current 4% price effectively prices a scenario where 2026 is unprecedented in scale — eight times worse than the 2019 record.
Our 18% estimate rests on several drivers. Kindergarten MMR coverage has slipped to about 92.7%, below the 95% herd-immunity threshold, and is falling further in some states. Rising vaccine exemptions and weakened school requirements create clusters of susceptible children. Imported cases from Europe and other regions with active measles circulation are increasingly common, and each introduction into an under-vaccinated community can seed chain transmission. The model incorporates seasonality, outbreak history and recent growth in incidence.
The market may underprice tail risk: extreme-event contracts are often cheap because traders dislike holding low-probability outcomes. For the outcome to win, a large multi-focal outbreak with sustained transmission across several under-vaccinated communities simultaneously is needed, not isolated importations.
Main risks: the 10,000 threshold remains very high, and even a serious outbreak may stay in the hundreds. Stronger vaccination campaigns, tighter school requirements or rapid containment of clusters could push the probability toward zero. The idea is invalidated if cumulative cases remain in the low hundreds by mid-2026.
Not investment advice. Trade at your own risk.